3M vs Altria
Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (MMM) industrial conglomerate with $23.1B revenue and 60K+ products (Scotch, Post-it, Nexcare); 2024 healthcare spinoff as Solventum after resolving $16B+ in PFAS and earplug litigation.
About
3M is a Saint Paul, Minnesota-based global manufacturing conglomerate producing over 60,000 products across four business segments — Safety & Industrial (protective equipment, adhesive tapes, abrasives), Transportation & Electronics (automotive films, electronics materials, optical products), Health Care (medical supplies, dental products, health information systems), and Consumer (Scotch tape, Post-it notes, Nexcare healthcare products). Listed on NYSE (NYSE: MMM), 3M generated $23.1 billion in revenue in fiscal year 2024 and employs approximately 87,000 people globally, making it one of the most diversified industrial companies in the US.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
About
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.